生醫創新 多元啟動-Johnson & Johnson Innovation、台大醫院、Senti Biosciences與西門子等專家開講，線上報名今(7/20)截止！
Explore Multiple Pathways to Healthcare Innovation
With more and more avenues to healthcare innovation and biopharma discovery, it is key to develop a good strategy and identify the most suitable platform to build innovation. Join us at BIO AsiaâTaiwan 2022
for talks by Dr. Chii-Wann Lin, Vice President and General Director of
the Biomedical Technology and Device Research Laboratories at the
Industrial Technology Research Institute (ITRI); Dr. Stephen Lee, Director of Early Innovation Partnering for North Asia at Johnson & Johnson Innovation Asia Pacific; Dr. Sharon Chan, Head of Johnson & Johnson Innovation â JLABS Asia Pacific; and Dr. Wei Wu, Principal of Venture Investments at Johnson & Johnson Innovation â JJDC, followed by a panel discussion on Accelerating Innovation Through External Collaboration. In addition, an independent session on Novel Platforms for Biopharma Discovery is also planned, headed by the Biomedical Translation Research Center (BioTReC) of the Academia Sinica, Taiwan, and featuring lectures by Dr. Timothy K. Lu, Cofounder & CEO of Senti Biosciences and Associate Professor of MIT Biological Engineering and Electrical Engineering and Computer Science; Dr. Pui-Yan Kwok, Distinguished Research Fellow and Director of the Institute of Biomedical Sciences at Academia Sinica; Dr. Ying Chih Chang, Professor of the Genomics Research Center at Academia Sinica and CEO of AcroCyte Therapeutics; and Dr. Tristan Bepler, Group Leader of the Simons Machine Learning Center at the New York Structural Biology Center, and Co-Founder and CEO of OpenProtein.AI. Registration closes on July 20:Register now to get access to the latest insights and trends!
Who should attend:
Drivers of change and innovation in industry or academia.
Executives seeking external partnership and collaboration.